Distribution of C-reactive protein values in the United States [7]

New England Journal of Medicine

Volumn 352, Issue 15, 2005, Pages 1611-1613

  Woloshin, Steven ^a   Schwartz, Lisa M ^a  

^a VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGE; AGED; CARDIOVASCULAR DISEASE; DISEASE MARKER; ETHNOLOGY; FEMALE; HUMAN; LETTER; MALE; NUTRITIONAL STATUS; PRIORITY JOURNAL; RACE; SEX DIFFERENCE; UNITED STATES; MIDDLE AGED; REFERENCE VALUE;

AGE FACTORS; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; SEX FACTORS; UNITED STATES;

EID: 16844375873     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200504143521525     Document Type: Letter

References (4)

1. Centers for Disease Control and Prevention. NHANES 2000-1 General data release document. (Accessed March 25, 2005, at http://www.cdc.gov/nchs/about/ major/nhanes/nhanes01-02.htm.)
2. Centers for Disease Control and Prevention. NHANES 2000-1 Analytic guidelines (June 2004). (Accessed March 25, 2005, at http://www.cdc.gov/nchs/ about/major/nhanes/nhanes01-02.htm.)
3. Ridker PM. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and drug design of the JUPITER trial. Circulation 2003;108: 2292-7.
4. Ridker PM, Cannon CP, Morrow D, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005;352: 20-8.